Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Welles

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
The Journal of School Health|April 14, 2000
The Minnesota DARE PLUS Project: creating community partnerships to prevent drug use and violenceC L Perry, K A Komro, S Veblen-Mortenson, et al.
The Journal of Infectious Diseases|October 9, 1999
Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infectionA Manns, W J Miley, R J Wilks, et al.
Annals of Internal Medicine|March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working GroupR T D'Aquila, V A Johnson, S L Welles, et al.
AIDS (London, England)|March 15, 2000
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study GroupS L Welles, J Pitt, R Colgrove, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
International Journal of Cancer|February 27, 1999
A study of adult T-cell leukemia/lymphoma incidence in central BrooklynP H Levine, H Dosik, E M Joseph, et al.
Statistics in Medicine|November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshopJ M Albert, J P Ioannidis, P Reichelderfer, et al.
The Journal of Infectious Diseases|October 1, 1996
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 TeamS L Welles, J B Jackson, B Yen-Lieberman, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
The Journal of School Health|April 14, 2000
The Minnesota DARE PLUS Project: creating community partnerships to prevent drug use and violenceC L Perry, K A Komro, S Veblen-Mortenson, et al.
The Journal of Infectious Diseases|October 9, 1999
Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infectionA Manns, W J Miley, R J Wilks, et al.
Annals of Internal Medicine|March 15, 1995
Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy. AIDS Clinical Trials Group Protocol 116B/117 Team and the Virology Committee Resistance Working GroupR T D'Aquila, V A Johnson, S L Welles, et al.
AIDS (London, England)|March 15, 2000
HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study GroupS L Welles, J Pitt, R Colgrove, et al.
The Journal of Infectious Diseases|October 1, 1996
Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. AIDS Clinical Trials Group (ACTG) 116B/117 Study Team. ACTG Virology Committee Resistance and HIV-1 RNA Working GroupsR W Coombs, S L Welles, C Hooper, et al.
International Journal of Cancer|February 27, 1999
A study of adult T-cell leukemia/lymphoma incidence in central BrooklynP H Levine, H Dosik, E M Joseph, et al.
Statistics in Medicine|November 20, 1998
Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshopJ M Albert, J P Ioannidis, P Reichelderfer, et al.
The Journal of Infectious Diseases|October 1, 1996
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 TeamS L Welles, J B Jackson, B Yen-Lieberman, et al.
Pageof 3